• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Alcobra Ltd. (ADHD)

    -NasdaqGM
    5.01 Down 0.20(3.84%) Feb 5, 4:00PM EST
    Prev Close:5.21
    Open:5.20
    Bid:N/A
    Ask:6.89 x 100
    1y Target Est:14.00
    Beta:0.294452
    Next Earnings Date:17-Feb-16ADHD Earnings announcement
    Day's Range:4.97 - 5.20
    52wk Range:4.27 - 9.50
    Volume:45,137
    Avg Vol (3m):184,184
    Market Cap:137.06M
    P/E (ttm):N/A
    EPS (ttm):-1.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADHD

    Comparison

    Symbol% ChgMkt Cap
    ADHDDown 3.84%137.06M
    JNJDown 3.23%278.19B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.94
    Quarterly EPS Est (Dec-15) :-0.24
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutama... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback